objectiveclinician
resourcepoor
countri
need
identifi
patient
dengu
use
readilyavail
data
object
systemat
review
identifi
clinic
laboratori
featur
differenti
dengu
fever
df
andor
dengu
hemorrhag
fever
dhf
febril
ill
ofi
dengueendem
popul
review
literatur
includ
english
public
compar
dengu
ofi
resultsamong
studi
review
meet
criteria
inclus
studi
includ
prospect
cohort
studi
five
casecontrol
studi
seven
studi
assess
age
four
assess
children
four
assess
adult
patient
dengu
significantli
lower
platelet
white
blood
cell
wbc
neutrophil
count
higher
frequenc
petechia
ofi
patient
higher
frequenc
myalgia
rash
hemorrhag
sign
lethargyprostr
arthralgiajoint
pain
higher
hematocrit
report
adult
patient
dengu
children
multivari
model
includ
platelet
count
wbc
rash
sign
liver
damag
howev
none
high
statist
valid
none
consid
chang
clinic
featur
cours
ill
conclusionssever
individu
clinic
laboratori
variabl
distinguish
dengu
ofi
howev
variabl
may
depend
age
publish
multivari
model
valid
studi
design
popul
diagnost
criteria
data
collect
method
differ
wide
across
studi
major
studi
identifi
specif
etiolog
ofi
prospect
studi
need
construct
valid
generaliz
algorithm
guid
differenti
diagnosi
dengu
endem
countri
nih
public
access
classic
dengu
fever
df
viral
ill
transmit
bite
infect
mosquito
usual
aed
aegypti
aed
albopictu
halstead
ill
endem
tropic
region
affect
million
peopl
worldwid
annual
gibbon
vaughn
dengu
ill
rang
nonspecif
febril
ill
df
sever
ill
bleed
tendenc
thrombocytopenia
plasma
leakag
dengu
hemorrhag
fever
dhf
dengu
viru
denv
complex
consist
four
distinct
serotyp
primari
infect
one
serotyp
provid
lifelong
immun
infect
serotyp
increas
risk
sever
dengu
ill
dhf
upon
secondari
infect
differ
serotyp
rothman
solomon
mallewa
develop
countri
epidem
febril
ill
includ
measl
typhoid
fever
leptospirosi
sever
acut
respiratori
syndrom
sar
confus
df
dietz
et
al
flanneri
et
al
karand
et
al
watt
et
al
wildersmith
et
al
present
df
febril
ill
may
share
similar
clinic
featur
includ
headach
myalgia
rash
clinic
featur
dhf
bleed
plasma
leakag
seen
initi
febril
phase
subsid
typic
third
fourth
day
fever
patient
classifi
dhf
accord
guidelin
base
follow
four
sign
fever
thrombocytopenia
platelet
count
bleed
tendenc
posit
tourniquet
test
spontan
bleed
plasma
leakag
evid
pleural
effus
ascit
hemoconcentr
world
health
organ
howev
find
may
appear
patient
alreadi
critic
ill
patient
suspect
dengu
includ
patient
febril
ill
sometim
hospit
unnecessarili
observ
ensur
characterist
dhf
develop
hospit
patient
suspect
dengu
shown
signific
financi
burden
develop
countri
clark
et
al
suaya
et
al
ideal
sever
df
dhf
case
hospit
confirm
dengu
diagnosi
serolog
test
may
take
sever
day
evid
plasma
leakag
may
difficult
measur
schwartz
et
al
furthermor
expens
laboratori
test
may
avail
resourcepoor
countri
popul
access
sophist
laboratori
tool
need
earli
clinic
simpl
laboratori
indic
provid
reliabl
diagnosi
dengu
prior
hospit
earli
distinct
dengu
ofi
could
help
clinician
identifi
patient
close
monitor
sign
dhf
differ
clinic
laboratori
featur
dengu
febril
ill
report
howev
publish
studi
vari
consider
term
durat
symptom
age
patient
qualiti
studi
could
impact
clinic
applic
differ
object
systemat
review
identifi
clinic
laboratori
featur
differenti
df
andor
dhf
febril
ill
identifi
gap
current
knowledg
electron
search
pubm
global
health
databas
use
combin
medic
subject
head
mesh
text
word
conduct
search
term
group
follow
indic
denguediagnosi
clinic
aspect
clinic
featur
clinic
manifest
clinic
characterist
clinic
present
physic
sign
physic
symptom
dengu
dengu
fever
dengu
hemorrhag
fever
dengu
haemorrhag
fever
articl
obtain
electron
paper
form
studi
includ
met
follow
criteria
publish
octob
english
includ
comparison
patient
df
andor
dhf
ofi
patient
abstract
exclud
studi
prior
improv
reliabl
laboratori
confirm
reflect
chang
global
distribut
dengu
dhf
exclus
also
help
limit
number
paper
requir
review
studi
exclud
use
travel
travel
mesh
term
assess
popul
dengueendem
area
assess
titl
abstract
done
exclud
nonhuman
studi
studi
assess
molecular
detect
method
studi
compar
patient
dengu
ofi
qualiti
select
studi
assess
use
modifi
version
strengthen
report
observ
studi
epidemiolog
strobe
statement
von
elm
et
al
strobe
qualiti
assess
checklist
observ
studi
consist
item
strobe
modifi
ad
question
serolog
method
use
confirm
dengu
diagnosi
use
viral
isol
whether
studi
base
singl
dengu
outbreak
transmiss
season
use
viral
isol
increas
score
wherea
singl
outbreak
studi
receiv
addit
point
qualiti
score
number
item
strobe
checklist
address
percentag
total
number
item
applic
minimum
maximum
studi
qualiti
assess
exclud
select
articl
character
studi
design
studi
locat
type
patient
outpati
inpati
age
patient
type
dengu
ill
primari
secondari
df
dhf
method
confirm
dengu
viral
isol
elisa
durat
ill
clinic
laboratori
featur
initi
search
retriev
articlesabstract
figur
exclud
studi
includ
travel
travel
publish
prior
nonenglish
studi
duplic
base
titleabstract
assess
total
articl
select
data
abstract
among
two
unavail
review
ali
et
al
zahur
ur
et
al
fortynin
articl
review
addit
supplement
tabl
exclud
follow
reason
lack
statist
comparison
dengu
ofi
lack
ofi
comparison
group
qualiti
assess
one
limit
number
dengu
case
nine
one
compar
environment
factor
one
short
report
lack
necessari
abstract
data
total
publish
articl
includ
review
characterist
includ
studi
list
tabl
substanti
heterogen
studi
design
inclus
criteria
among
prospect
cohort
studi
five
casecontrol
studi
singl
outbreak
studi
conclud
within
one
year
major
studi
carri
dengueendem
region
southeast
asiapacif
except
three
studi
america
brazil
nicaragua
puerto
rico
one
studi
australia
includ
studi
qualiti
assess
rate
rang
one
studi
assess
outpati
one
studi
gave
inform
type
patient
includ
four
studi
assess
adult
defin
year
old
four
studi
assess
children
defin
month
year
old
seven
studi
assess
age
group
includ
infant
sampl
size
laboratoryconfirm
dengu
patient
rang
sampl
size
ofi
patient
rang
studi
use
hemagglutin
inhibit
andor
elisa
assay
serolog
confirm
denv
infect
seven
studi
also
use
viral
isol
laboratori
confirm
infect
six
studi
reli
singl
blood
sampl
serolog
studi
convalesc
sampl
shortest
time
acut
convalesc
sampl
three
day
low
et
al
howev
studi
obtain
addit
sampl
week
five
studi
use
durat
fever
prior
enrol
part
select
criteria
kalayanarooj
et
al
low
et
al
c
x
phuong
et
al
h
l
phuong
et
al
suwandono
et
al
four
studi
mention
durat
fever
prior
enrol
use
enrol
criteria
chadwick
et
al
depari
et
al
sawasdivorn
et
al
wildersmith
et
al
six
studi
nt
mention
durat
fever
prior
enrol
bruce
et
al
buchi
et
al
hammond
et
al
karand
et
al
mcbride
et
al
nunesaraujo
et
al
mean
durat
ill
studi
period
note
nine
studi
rang
day
two
studi
analyz
clinic
laboratori
symptom
accord
day
ill
depari
et
al
kalayanarooj
et
al
percentag
dhf
case
determin
eight
studi
rang
nunesaraujo
et
al
kalayanarooj
et
al
percentag
secondari
infect
determin
seven
studi
rang
low
et
al
kalayanarooj
et
al
studi
statist
compar
patient
dhf
patient
ofi
howev
kalayanarooj
et
al
list
frequenc
symptom
separ
dhf
ofi
two
studi
separ
primari
secondari
infect
analysi
neither
found
signific
differ
sign
symptom
patient
primari
secondari
infect
low
et
al
h
l
phuong
et
al
two
studi
use
distinct
serolog
identifi
comparison
groupeith
sar
wildersmith
et
al
leptospirosi
bruce
et
al
three
addit
studi
provid
inform
specif
diagnos
ofi
group
chadwick
et
al
karand
et
al
c
x
phuong
et
al
seven
studi
use
data
collect
present
make
comparison
bruce
et
al
chadwick
et
al
kalayanarooj
et
al
low
et
al
c
x
phuong
et
al
h
l
phuong
et
al
wildersmith
et
al
studi
clearli
defin
data
use
statist
comparison
maximum
minimum
mean
median
tabl
indic
direct
associ
clinic
laboratori
featur
report
least
two
studi
one
found
signific
differ
dengu
ofi
patient
bruce
et
al
phuong
et
al
show
signific
increasesdecreas
mean
likelihood
dengu
versu
ofi
rel
risk
odd
ratio
studi
report
independ
associ
differ
proport
categor
variabl
mean
continu
variabl
patient
dengu
ofi
clinic
laboratori
featur
report
least
two
prospect
two
retrospect
studi
direct
associ
similar
except
gender
headacheretroorbit
pain
consist
score
evalu
direct
associ
variabl
across
studi
measur
variabl
weight
qualiti
assess
percentag
studi
demograph
indicatorsno
consist
associ
observ
age
occurr
dengu
across
studi
within
agegroup
studi
two
retrospect
studi
show
significantli
higher
frequenc
dengu
among
male
bruce
et
al
wildersmith
et
al
clinic
findingsamong
studi
assess
adult
consist
higher
frequenc
rash
hemorrhag
sign
report
patient
dengu
compar
patient
ofi
chadwick
et
al
mcbride
et
al
wildersmith
et
al
howev
frequenc
hemorrhag
sign
show
differ
dengu
ofi
four
studi
assess
children
depari
et
al
hammond
et
al
nunesaraujo
et
al
h
l
phuong
et
al
hammond
et
al
report
hemorrhag
sign
specif
categori
frequenc
melena
hematemesi
higher
children
dengu
adult
four
seven
studi
assess
age
group
frequenc
rash
also
higher
patient
dengu
depari
et
al
hammond
et
al
nunesaraujo
et
al
howev
two
studi
assess
children
found
signific
associ
rash
karand
et
al
sawasdivorn
et
al
three
studi
assess
children
found
higher
frequenc
petechia
among
patient
dengu
one
studi
measur
petechia
adult
also
found
posit
associ
chadwick
et
al
kalayanarooj
et
al
c
x
phuong
et
al
sawasdivorn
et
al
greater
percentag
patient
dengu
report
lethargyprostr
arthralgiajoint
pain
two
studi
assess
adult
mcbride
et
al
howev
lethargyprostr
report
studi
assess
children
pattern
arthralgiajoint
pain
inconsist
studi
children
age
two
studi
includ
children
frequenc
anorexia
higher
among
patient
dengu
kalayanarooj
et
al
c
x
phuong
et
al
tast
alter
skin
sensit
frequent
report
patient
dengu
two
studi
assess
adult
nonspecif
symptom
headacheretroorbit
pain
abdomin
pain
diarrhea
vomit
itchingprur
nausea
show
inconsist
nonsignific
associ
durat
fever
prior
studi
period
show
inconsist
nonsignific
associ
occurr
dengu
versu
ofi
laboratori
indicatorsneutrophil
lymphocyt
count
significantli
lower
patient
dengu
compar
patient
ofi
among
studi
measur
variabl
chadwick
et
al
depari
et
al
hammond
et
al
kalayanarooj
et
al
karand
et
al
low
et
al
c
x
phuong
et
al
wildersmith
et
al
studi
measur
wbc
found
lower
wbc
count
among
patient
dengu
except
one
retrospect
studi
sawasdivorn
et
al
show
associ
nine
studi
found
lower
platelet
count
among
patient
dengu
compar
ofi
patient
two
three
studi
measur
prothrombin
time
found
significantli
lower
valu
among
patient
dengu
chadwick
et
al
wildersmith
et
al
bruce
et
al
chadwick
et
al
found
lower
creatinin
level
lower
percentag
jaundic
among
patient
dengu
higher
level
hepat
transaminas
astalt
found
patient
dengu
three
four
studi
chadwick
et
al
kalayanarooj
et
al
wildersmith
et
al
increas
hematocrit
hemoglobin
level
observ
among
patient
dengu
two
adultonli
studi
chadwick
et
al
wildersmith
et
al
howev
hematocrit
show
inconsist
associ
three
childrenonli
studi
laboratori
measur
total
protein
aptt
urea
also
show
inconsist
pattern
occurr
dengu
chadwick
et
al
wildersmith
et
al
kalayanarooj
et
al
hammond
et
al
studi
measur
pleural
effus
ascit
kalayanarooj
et
al
report
higher
frequenc
pleural
effus
patient
dhf
compar
df
ofi
hammond
et
al
found
increas
odd
pleural
effus
ascit
among
children
adult
dengu
tabl
list
addit
symptom
show
associ
dengu
ofi
report
one
studi
review
tabl
list
symptom
measur
one
studi
statist
associ
dengu
ofi
common
laboratori
testssodium
potassium
glucos
alkalin
phosphatas
lactat
dehydrogenasemeasur
chadwick
et
al
wildersmith
et
al
show
differ
dengu
ofi
chadwick
et
al
depari
et
al
karand
et
al
mcbride
et
al
c
x
phuong
et
al
sawasdivorn
et
al
wildersmith
et
al
carri
multivari
regress
analysi
attempt
distinguish
patient
dengu
ofi
tabl
among
seven
studi
studi
measur
wbc
includ
variabl
final
model
show
reduc
wbc
count
patient
dengu
compar
patient
ofi
three
seven
studi
includ
measur
liver
function
final
model
wildersmith
et
al
found
increas
ast
result
increas
odd
dengu
phuong
et
al
found
hepatomegali
result
increas
adjust
odd
dengu
hand
chadwick
et
al
found
lower
bilirubin
valu
result
increas
adjust
odd
dengu
chadwick
et
al
one
studi
report
platelet
count
includ
variabl
final
model
three
studi
includ
sign
bleed
petechia
hematocrit
posit
tourniquet
test
final
model
show
posit
sign
bleed
increas
odd
dengu
mcbride
et
al
c
x
phuong
et
al
sawasdivorn
et
al
three
studi
also
show
higher
frequenc
rash
among
dengu
patient
final
model
chadwick
et
al
depari
et
al
mcbride
et
al
final
model
karand
et
al
neg
predict
valu
npv
studi
report
npv
final
model
posit
predict
valu
ppv
find
review
suggest
sever
clinic
laboratori
measur
could
potenti
distinguish
patient
dengu
ofi
low
platelet
count
decreas
wbc
neutrophil
independ
associ
presenc
dengu
compar
patient
ofi
adult
children
variabl
well
sign
rash
liver
damag
also
use
multivari
model
distinguish
patient
dengu
ofi
howev
unlik
singl
indic
use
clinic
practic
sign
symptom
present
diseas
viral
hepat
leptospirosi
also
endem
area
high
preval
dengu
low
platelet
count
current
use
criterion
diagnosi
dhf
world
health
organ
caus
thrombocytopenia
dengu
unknown
howev
decreas
product
platelet
df
increas
destruct
platelet
dhf
describ
cardier
et
al
kalayanarooj
et
al
attribut
reduct
wbc
bone
marrow
suppress
dengu
viru
la
russa
inni
howev
depari
et
al
argu
laboratori
measur
denguespecif
earli
stage
diseas
depari
et
al
alter
microvascular
endothelium
patient
dengu
thought
lead
higher
likelihood
hemorrhag
bandyopadhyay
et
al
cardier
et
al
review
increas
frequenc
hemorrhag
observ
adult
dengu
associ
dengu
studi
includ
children
howev
hammond
et
al
demonstr
type
hemorrhag
eg
hematemesi
melena
associ
dengu
children
suggest
type
hemorrhag
manifest
seen
dengu
may
depend
age
patient
sign
rash
indic
liver
damag
combin
variabl
age
myalgia
wbc
count
platelet
count
may
help
establish
diagnost
algorithm
distinguish
dengu
ofi
patient
sever
studi
use
multivari
regress
model
discrimin
dengu
ofi
howev
publish
model
linger
statist
question
wildersmith
et
al
present
model
larg
odd
ratio
howev
confid
interv
model
also
larg
question
overfit
colinear
discuss
depari
et
al
present
model
unusu
small
odd
ratio
categor
variabl
low
platelet
count
may
applic
clinic
set
none
regress
model
valid
use
train
test
dataset
approach
furthermor
generaliz
model
question
sinc
deriv
singl
outbreak
studi
exampl
karand
et
al
singl
outbreak
studi
present
model
ppv
patient
dengu
model
sinc
author
select
variabl
analysi
review
unabl
determin
whether
specif
valu
versu
increas
decreas
particular
variabl
use
algorithm
identifi
patient
dengu
would
need
appli
earli
ill
order
use
reduc
unneed
hospit
review
highlight
weak
literatur
studi
indic
day
ill
clinic
laboratori
measur
assess
kalayanarooj
et
al
depari
et
al
separ
analyz
clinic
laboratori
measur
accord
day
ill
kalayanarooj
et
al
show
posit
neg
predict
valu
individu
variabl
differ
depend
stage
ill
depari
et
al
show
frequenc
clinic
laboratori
symptom
vari
accord
day
ill
five
includ
studi
casecontrol
studi
reli
review
medic
record
patient
recal
could
bia
find
studi
furthermor
two
casecontrol
studi
use
standard
data
collect
form
six
studi
reli
serolog
test
singl
blood
sampl
could
increas
risk
misclassif
patient
dengu
two
studi
serolog
confirm
diagnos
ofi
group
differ
found
patient
dengu
patient
ofi
depend
specif
comparison
febril
ill
bruce
et
al
use
leptospirosi
comparison
group
studi
found
differ
platelet
count
astalt
ill
similar
characterist
dengu
leptospirosi
clearli
difficult
discrimin
basi
clinic
algorithm
durat
ill
prior
studi
enrol
distinguish
patient
dengu
ofi
four
five
studi
durat
ill
prior
present
may
applic
distinguish
patient
dhf
patient
df
averag
patient
dhf
sever
ill
may
requir
hospit
extend
period
time
defervesc
comparison
df
studi
review
prospect
compar
clinic
sign
symptom
patient
dhf
patient
df
ofi
therefor
unabl
make
conclus
review
sign
symptom
prospect
distinguish
patient
dhf
patient
df
ofi
perhap
surpris
studi
measur
hematocrit
found
signific
differ
dengu
ofi
howev
hemoconcentr
featur
dhf
df
defin
base
comparison
patient
baselin
hematocrit
rather
singl
measur
review
sever
limit
interrat
intrarat
reliabl
qualiti
assess
rate
strobe
mainli
score
report
may
impact
abil
extract
inform
rather
qualiti
studi
lack
establish
qualiti
assess
rate
scale
evalu
observ
studi
strobe
give
merit
studi
address
limit
may
explain
retrospect
studi
highest
qualiti
assess
rate
studi
robust
statist
method
dengu
ofi
group
heterogen
former
includ
milder
sever
diseas
latter
includ
wide
varieti
possibl
etiolog
studi
fail
includ
durat
fever
ill
analysi
could
affect
interpret
timedepend
variabl
also
dengu
outbreak
occur
countri
english
primari
languag
thu
restrict
englishlanguag
studi
may
affect
find
review
final
mani
studi
note
day
ill
clinic
laboratori
data
measur
make
imposs
determin
whether
data
distinguish
dengu
ofi
earli
cours
ill
lowcost
rapid
sensit
laboratori
assay
wide
avail
diagnosi
dengu
diagnost
algorithm
continu
import
place
clinic
manag
addit
prospect
studi
need
establish
algorithm
valid
gener
distinguish
dengu
ofi
df
dhf
earli
stage
ill
furthermor
longitudin
studi
routin
document
clinic
laboratori
sign
symptom
throughout
patient
cours
ill
would
provid
much
need
data
develop
predict
model
distinguish
patient
dengu
requir
hospit
patient
ofi
easili
applic
clinic
algorithm
could
favor
impact
economi
dengueendem
develop
countri
refer
web
version
pubm
central
supplementari
materi
list
includ
studi
indic
first
author
studi
design
year
studi
perform
locat
studi
countri
type
patient
inpati
outpati
mix
includ
inpati
outpati
sampl
size
dengu
number
confirm
dengu
patient
ofi
number
febril
ill
patient
viral
isol
durat
fever
prior
enrol
among
dengu
patient
enrol
durat
fever
studi
period
modifi
strobe
qualiti
assess
rate
shown
percentag
symptom
laboratori
measur
assess
least
two
studi
one
studi
show
associ
dengu
symptom
consist
score
bruce
sign
symptom
addit
indic
report
one
studi
show
signific
associ
dengu
ofi
nonsignific
sign
symptom
addit
indic
report
one
studi
phuong
